fidgeting with [1%:1.4 1.8 ULN 6% 5% Grade 3 > 1.9 3.4 ULN 2% 1% Grade 4 > 3.4 ULN 0%] FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Drug Status Rx Availability Prescription only B Pregnancy Category No proven risk in humans N/A CSA Schedule Not a controlled drug 9 years Approval History FDA approved 2008 Manufacturers Janssen Pharmaceuticals, Inc. Johnson & Johnson Drug Class NNRTIs Related Drugs NNRTIs Sustiva , efavirenz , nevirapine , Edurant , etravirine , Viramune HIV Infection Truvada , Atripla , Norvir , Viread , Isentress , Prezista , Stribild , lamivudine , abacavir , tenofovir , Epzicom , Reyataz , ritonavir , Complera , darunavir , emtricitabine , Kaletra , Sustiva , Epivir , efavirenz , nevirapine , atazanavir , raltegravir , Selzentry , Lexiva , More... Intelence Rating 2 User Reviews 6.8 /10 2 User Reviews 6.8 Rate it! Intelence Images Intelence 100 mg (TMC125 100) View larger images charges
the stainless steel Intelence final result
EmoticonEmoticon